Journal article
Phase I study of OSI-906, dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR) in combination with erlotinib (E) in patients with advanced solid tumors.
- Publication status:
- Published
Actions
Authors
- Journal:
- JOURNAL OF CLINICAL ONCOLOGY More from this journal
- Volume:
- 28
- Issue:
- 15
- Publication date:
- 2010-05-20
- ISSN:
-
0732-183X
- Pubs id:
-
pubs:457370
- UUID:
-
uuid:878464f8-20b8-48d9-bfd0-7340ce914549
- Local pid:
-
pubs:457370
- Source identifiers:
-
457370
- Deposit date:
-
2014-05-14
Terms of use
- Copyright date:
- 2010
If you are the owner of this record, you can report an update to it here: Report update to this record